Page last updated: 2024-11-04

gatifloxacin and Jaundice, Obstructive

gatifloxacin has been researched along with Jaundice, Obstructive in 1 studies

Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.

Jaundice, Obstructive: Jaundice, the condition with yellowish staining of the skin and mucous membranes, that is due to impaired BILE flow in the BILIARY TRACT, such as INTRAHEPATIC CHOLESTASIS, or EXTRAHEPATIC CHOLESTASIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tunuguntla, A1
Patel, M1
Hudgins, LB1

Other Studies

1 other study available for gatifloxacin and Jaundice, Obstructive

ArticleYear
Gatifloxacin-induced cholestatic hepatitis--a challenging diagnosis.
    Tennessee medicine : journal of the Tennessee Medical Association, 2005, Volume: 98, Issue:3

    Topics: Aged; Chemical and Drug Induced Liver Injury; Fluoroquinolones; Gatifloxacin; Humans; Jaundice, Obst

2005